Propyliodone
Chemical compound
- V08AD03 (WHO)
- propyl 2-(3,5-diiodo-4-oxo-1,4-dihydropyridin-1-yl)acetate
- 587-61-1
Y
- 4949
- 4780
N
- 5NPJ6BPX36
- ChEMBL1200821
N
- DTXSID6023527
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I
InChI
- InChI=1S/C10H11I2NO3/c1-2-3-16-9(14)6-13-4-7(11)10(15)8(12)5-13/h4-5H,2-3,6H2,1H3
N
- Key:ROSXARVHJNYYDO-UHFFFAOYSA-N
N
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Propyliodone (INN, trade name Dionosil) is a molecule used as a contrast medium in bronchography.[1] It was developed by a team at Imperial Chemical Industries[2] in the late 1930s.
References
- v
- t
- e
Contrast media (V08)
Iodinated, Water soluble |
| ||||||
---|---|---|---|---|---|---|---|
Iodinated, Water insoluble |
| ||||||
Non-iodinated |
Paramagnetic | |
---|---|
Superparamagnetic |
|
Other |
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e